Whats New

Preventing deep vein thrombosis by improving blood flow in the calf veins of the leg

Deep vein thrombosis is a serious condition that occurs when blood clots form inside a vein located deep in your leg. One possible way to help reduce the risk of blood clots is to increase the amount of blood flow through the calf veins. One device that can do that is the Geko device.
Download the article

Read more »

Thrombosis Voices in Partnership Programme (ViPs) for patients

AntiCoagulation Europe (ACE) are working in partnership with LEO Pharma and their research partners to find people who have cancer and have experienced thrombosis (usually referred to as a blood clot, Deep Vein Thrombosis (DVT) or a Pulmonary Embolism (PE) to join their ViP programme. The ViP programme is designed to bring patients with similar experiences together, so that they can share their stories and help to build activities and ideas which will improve the patient experience for many others. Please click on the title above to find out more.

Read more »

NICE publishes options for local implementation of Novel Oral Anticoagulants

NICE has issued technology appraisal guidance on the use of the 4 non-vitamin K antagonist oral anticoagulants (NOACs), apixaban, dabigatran, edoxaban and rivaroxaban, in several clinical settings. All 4 NOACs must be included in local formularies for use in line with this guidance, with no additional funding or formulary restrictions. nice.org.uk/guidance/ktt16

Read more »

Buy copies of our magazine InReview online

You can now buy individual copies of our magazine InReview online for £3.00. Just click on the flashing image above. If you want to support us on a long term basis you can still sign up to be a member on the join us page and receive 4 copies for £10.00. We hope you enjoy reading InReview

Read more »

NICE recommends Edoxaban for two indications

The National Institute for Health and Care Excellence (NICE) has recommended Edoxaban (Lixiana) as an option for the treatment and secondary prevention of deep vein thrombosis and pulmonary embolism and for preventing stroke and systemic embolism in people with non-valvular atrial fibrillation

Read more »

NICE publishes Quality Standard for Atrial Fibrillation

This quality standard covers identification, treatment and management of atrial fibrillation (including paroxysmal, persistent and permanent atrial fibrillation, and atrial flutter) in adults (18 years and older). It includes a Quality Statement on Self-managment with coagulometers for people with AF and also a Quality Statement on not using aspirin as a sole therapy for stroke prevention in AF.

Read more »

Ready for Change? An Audit of Local Commissioning

ACE’s new report shows there is a worrying trend that healthcare commissioners are not aware of how many people in their locality have one of the early warning signs of being at an increased risk of a stroke, atrial fibrillation (AF). With less than half of clinical commissioning groups (CCGs) having assessed the prevalence of the condition in their area, and almost two thirds not having assessed the cost of their anticoagulation service.

Read more »

NICE issues guidance for self-monitoring for people with AF or replacement heart valves

24th Sept 2014 The National Institute of Health and Care Excellence (NICE) has recommended self-monitoring of INR levels for people with atrial fibrillation and people with replacement heart valves - if the person prefers this form of testing and if the person or their carer is both physically and cognitively able to self-monitor effectively.

Read more »

NICE revises its guidance on Atrial Fibrillation

The National Institute for Health and Care Excellence (NICE) has revised its guidance on Atrial Fibrillation. It says that anticoagulation may be with Apixaban, Dabigatran Etixialte, Rivaroxaban or a Vitamin K Antagonist (warfarin). It also states that aspirin should no longer be used as a sole therapy for stroke prevention in AF.

Read more »

Dental Care for Patients Taking Anticoagulant or Antiplatelet Drugs

CLICK ON WORDS ABOVE AND HELP US BY COMPLETING THE QUESTIONNAIRE Help develop national clinical guidance for the management of patients needing dental treatment and who are taking anticoagulant or antiplatelet drugs. What is the aim of this questionnaire? The aim of this questionnaire is to explore patients’: • Views of their experiences of dental treatment in primary care when taking anticoagulant drugs. • Concerns they may have that might be addressed by the new guidance.

Read more »

AntiCoagulation Europe, PO Box 405, Bromley, Kent BR2 9WP. Registered Charity: 1090250
Privacy | Terms & Conditions © Anticoagulation Europe 2011
Web design by Bright White Space